Micronutrient Gaps and Supplement Use in a Diverse Cohort of Pregnant Women.

What Was Tested

This clinical trial looks at Copper (Supplement).

Estimate micronutrient intake from food and dietary supplements in a diverse cohort of pregnant women and compare intake to the Dietary Reference Intakes (DRIs).

Why It Was Studied

Micronutrition in pregnancy is critical to impact not only fetal growth and development but also long-term physical and psychiatric health outcomes.

Percent of participants whose intake was below the estimated average requirement (EAR) or adequate intake (AI) and above the tolerable upper limit (UL).

Who Took Part

According to the abstract, 1021 participants were involved.

PubMed tags the participants as women only.

Secondary analysis of women enrolled in a multi-site clinical trial of docosahexaenoic acid (DHA) supplementation who provided their dietary intake using the diet history questionnaire-II (n = 843) or multiple 24 h recalls (n = 178) at baseline and their intake of nutritional supplements at baseline through 30 days postpartum.

1021 participants from the parent trial who had reliable data for dietary intake, supplement intake, or both.

What Was Measured

Micronutrition in pregnancy is critical to impact not only fetal growth and development but also long-term physical and psychiatric health outcomes.

PubMed files the paper under topics including Choline, Cross-Sectional Studies, Diet, Dietary Supplements, Folic Acid, Iron and Magnesium.

The authors tagged it with the keywords nutrition and pregnancy.

What This Means in Plain Language

This is a clinical trial of Copper (Supplement) in 1021 participants.

With several hundred people or more, it is a fairly large study for this kind of research.

The abstract goes on to report its results in about 9 sentences; this page does not restate them, so read the paper for the findings and their limits.

The publication is from 2023 (Nutrients), a journal based in Switzerland.

More context: the Copper (Supplement) compound page, all human trials.